TrialAnnals of the rheumatic diseases2005

Histological evidence that infliximab treatment leads to downregulation of inflammation and tissue remodelling of the synovial membrane in spondyloarthropathy.

E Kruithof et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.